CRNX
CRNX
US22663K1079
Crinetics Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 7.696.000 1.039.000
640.7%
Cost of Revenue 1.076.000 --
--
Gross Profit 6.620.000 1.039.000
537.2%
523.389.000 339.893.000
54.0%
Operating Income -516.769.000 -338.854.000
52.5%
Pretax Income -465.137.000 -298.408.000
55.9%
Net Income Common Stockholders -465.317.000 -298.408.000
55.9%
-- --
--
-- --
--
ende